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Background and aims: Milk contains numerous nutrients. The content of n-3 fatty acids, the n-6/n-3 ratio, and
short- and medium-chain fatty acids may promote positive health effects. In Western societies, cow’s milk fat is
perceived as a risk factor for health because it is a source of a high fraction of saturated fatty acids. Recently, there
has been increasing interest in donkey’s milk. In this work, the fat and energetic value and acidic composition of
donkey’s milk, with reference to human nutrition, and their variations during lactation, were investigated. We also
discuss the implications of the acidic profile of donkey’s milk on human nutrition.
Methods: Individual milk samples from lactating jennies were collected 15, 30, 45, 60, 90, 120, 150, 180 and
210days after foaling, for the analysis of fat, proteins and lactose, which was achieved using an infrared milk
analyser, and fatty acids composition by gas chromatography.
Results: The donkey’s milk was characterised by low fat and energetic (1719.2kJ·kg-1) values, a high polyunsaturated
fatty acids (PUFA) content of mainly α-linolenic acid (ALA) and linoleic acid (LA), a low n-6 to n-3 FA ratio or
LA/ALA ratio, and advantageous values of atherogenic and thrombogenic indices. Among the minor PUFA,
docosahesaenoic (DHA), eicosapentanoic (EPA), and arachidonic (AA) acids were present in very small amounts
(<1%). In addition, the AA/EPA ratio was low (0.18). The fat and energetic values decreased (P < 0.01) during
lactation.
The fatty acid patterns were affected by the lactation stage and showed a decrease (P < 0.01) in saturated fatty
acids content and an increase (P < 0.01) in the unsaturated fatty acids content. The n-6 to n-3 ratio and the LA/ALA
ratio were approximately 2:1, with values <1 during the last period of lactation, suggesting the more optimal use of
milk during this period.
Conclusions: The high level of unsaturated/saturated fatty acids and PUFA-n3 content and the low n-6/n-3 ratio
suggest the use of donkey’s milk as a functional food for human nutrition and its potential utilisation for infant
nutrition as well as adult diets, particular for the elderly.
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The relationship between diet and health is one of the
keys for preventing disease and promoting well-being.
There is an increasing awareness of the role of dietary
lipids in health maintenance and disease prevention. Evi-
dence suggests that a high intake of saturated fatty acids
(SFA) from the diet may be associated with elevated* Correspondence: angelagabriella.dalessandro@uniba.it
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distribution, and reproduction in any mediumcardiovascular disease risk [1], and the association be-
tween diet and health is a decisive factor in consumer
food selection. In addition to the reduction of fat intake,
a change in the saturated/unsaturated fatty acid ratio
may contribute to improved human health [2].
A European study on fatty acid consumption reported
that milk and dairy products are great sources of SFAs [3].
Cow milk possesses poor polyunsaturated fatty acid
(PUFA) levels [4]. Donkey’s milk appears to contain
lower SFA amounts and higher essential fatty acid (EFA)e BioMed Central Ltd. This is an Open Access article distributed under the terms
(http://creativecommons.org/licenses/by/2.0), which permits unrestricted use,
, provided the original work is properly cited.
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limited amounts of long-chain PUFA; overall these find-
ings suggest that donkey’s milk is more like human milk
than is cow’s milk [5].
Recently, there has been increasing interest in donkey’s
milk due to its potential role in human nutrition and es-
pecially in paediatric dietetics [6-8].
The determination of the characteristics of donkey’s
milk is important for economic interest in human diets
and pharmaceuticals. Moreover, the milk composition is
affected by the stage of lactation [9,10].
Few studies on the characterisation of the lipid content
and energetic value of donkey’s milk [11,12] or on the
variation in milk fat content, energetic value and fatty
acid composition during lactation have been reported
[11,13]. Thus, a deeper knowledge of the fat and ener-
getic composition of this milk is necessary to understand
the physiological features of milk, particularly the fatty
acid composition, which is of great importance from a
nutritional standpoint [14].
The aim of this study was to investigate the fat and ener-
getic value and acidic composition of donkey’s milk over
seven months of lactation, and several parameters that
could be of interest to human nutrition were highlighted.
Methods
The experiment was conducted according to protocols
approved by the Italian Minister for Scientific Research
in accordance with EC regulations.
Milk samples and analyses
Milk samples were collected during an entire lactation
period of seven months (210 days) from nine healthy
pluriparous jennies of the Martina Franca breed, aged
from 6 to 12 year, with good body conditions (average
weight = 320 ± 30 kg; the average body condition was
3.3 ± 0.2 on a scale of 0 to 5 [15]). The animals were
reared under the semi-extensive conditions commonly
used in the typical breeding area (south-eastern Mur-
gia, Apulia region, southern Italy) (40°37’20” latitude;
60°17’44” longitude), based on natural grazing (7 to 10h
of pasture in one grazing session on natural scrub of
Ligustrum vulgare L., Arbustus unedo L., Pistacia Len-
tiscus, Quercus ilex L., Fraxinus ornu and Cistus s.p.)
with added oats (2 times per day; 2.0 to 2.5 kg
grain· d-1· jenny-1) and water ad libitum. The animals
were selected according to a close foaling date (± 7
days). During the lactation period the foals were with
their dams and were separated from them before milk-
ing (3 h). The asses were milked twice a day, in the
presence of foals placed in an adjacent box to allow vis-
ual contact, using a mechanical milker with a vacuum
level of 42 kPa, a pulse ratio of 50% and a pulse rate of
120 cycles/min [16].Individual milk samples, from morning and evening
milkings, were collected 15, 30, 45, 60, 90, 120, 150, 180,
and 210 days after foaling. Milk from the two daily milk-
ings was pooled and split into two aliquots for the ana-
lyses of fat, protein and lactose content and for the
determination of fatty acid composition. The milk sam-
ples were then preserved (−20°C) until analysis.
The fat, protein and lactose contents were determined
using an infrared milk analyser (Milkoscan 6000), previ-
ously standardised for donkey’s milk according to FIL-IDF
141C [17] to determine the gross energetic value. The
gross energetic value of milk, expressed in kJ·kg–1, was cal-
culated by the Perrin [18] formula, which considers a coef-
ficient of 9.11 for the fat percentage, 5.86 for the protein
percentage and 3.95 for the lactose percentage.
The fatty acids composition of the collected milk sam-
ples was determined using capillary gas chromatography.
The fat content of milk was extracted with chloroform-
methanol (2:1, vol/vol) using the method described by
Folch et al. [19]. The fatty acid composition in milk was
estimated using methyl esters prepared by direct transes-
terification, according to IUPAC method 2.301 [20]. The
analyses were performed using a Fison HRGC Mega 2
series gas chromatograph (Milan, Italy) with a flame-
ionisation detector fitted with WCOT fused-silica capil-
lary column (FFAP-CB coating, 25 m × 0.32 mm i.d. ×
0.30 μm film thickness, Chrompack, Middleburg, The
Netherlands) using the analytical conditions used by
Caponio et al. [21]. The separation was performed at pre-
programmed temperatures: 50°C for 3 min; 50–100°C at a
rate of 20°C/min; 100°C for 2 min; 100–240°C at a rate of
20°C/min; 240°C for 15 min. Hydrogen was the carrier gas
(flow rate, 2mL/min). The injector temperature was 270°C
(splitting ratio, 1:17) and the detector temperature was
300°C. Fatty acid peaks were identified using a compara-
tive analysis with standard reference mixtures. The fatty
acid content is expressed as percentage of the total identi-
fied fatty acids.
The desaturase index was calculated for three pairs of
fatty acids representing the products and substrates for
Δ9-desaturase as follows: cis-9 14:1/14:0, cis-9 16:1/16:0,
cis-9 18:1/18:0. For example the desaturase index for cis-
9 18:1 was (cis-9 18:1)/(cis-9 18:1+18:0). The atherogenic
(AI) and thrombogenic (TI) indices were calculated
using the Ulbricht and Southgate [22] equations.
Statistical analysis
Changes over time in the fat, energetic values and classes
or the individual fatty acids of milk from the jennies were
analysed by PROC MIXED for repeated measurements of
SAS [23]. A GLM procedure was used. The fixed effect
included the stage of lactation which was divided into 8
controls considering post-foaling days (d 15, 30, 60, 90,
120, 150, 180 and 210) for the fat composition and gross
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60, 90, 120, 150, 180 and 210) for the fatty acid compos-
ition, with the residual error being individual within a
given control of lactation. The differences among the
means were compared using Student’s t tests. The results
were considered significant when P ≤ 0.05.Results
Milk fat content and gross energy
The average percentage of milk fat is provided in Table 1
and was low (an average of 0.54%). The highest value oc-
curred at 15 and 30 days with a gradual decreasing trend
throughout the lactation period, becoming significant
(P < 0.05) at 210 days.
The gross energetic value of donkey’s milk on aver-
age was 1748.5 kJ·kg-1, with a significant (P < 0.05) de-
crease (− 10%) from day 15 to 210 (Table 1).Fatty acid composition
The acid classes of fat milk were statistically different
(P < 0.05) and were influenced by the lactation stage
(P<0.01). Overall, the average SFA content was higher
than the monounsaturated fatty acid (MUFA) and PUFA
content (Table 2).Table 2 Summarized data of milk fatty acid composition
(X ± SD)
Fatty acid composition
Saturated (SFA, %) 51.98 ± 5.13
Unsaturated (UFA, %) 48.02 ± 2.97Saturated fatty acids
The SFA content in the milk decreased significantly
(P < 0.01) during the lactation period (−33.9%), from an
average mean of 62.88% at day 15 to 41.54% at day 180
after foaling and then decreased slightly at day 210
(Figure 1, Table 3a).
Among the SFA, palmitic acid was observed to be the
most concentrated (C16:0 = 19.94% average, data not
presented). Lower concentration levels were observed
for capric (C10:0 = 10.78% average), lauric (C12:0 =
8.78% average), myristic (C14:0 = 6.98% average) and
caprylic (C8:0=6.20%) acids, with the lowest levelTable 1 Average fat (%, w/w) and gross energy content





15 d 0.72 ± 0.09 a 1857.3 a
30 d 0.71 ± 0.10 a 1831.5 a
60 d 0.65 ± 0.15 1780.9
90 d 0.54 ± 0.15 1749.6
120 d 0.55 ± 0.17 1764.1
150 d 0.50 ± 0.22 1690.6
180 d 0.48 ± 0.06 1668.4
210 d 0.42 ± 0.33 b 1645.6 b
a, b Means with different letters within the column differ significantly for
P < 0.05.observed for stearic acid (C18:0=1.82% average) (data
not presented).
Among the fatty acids found at concentrations greater
than 1%, palmitic acid (C16:0) exhibited a significant de-
crease in concentration at day 30 and day 90 (Tables 4,
3f ). The myristic acid (C14:0) concentration decreased
significantly from day 15 to day 120, day 150 and day
180 (Tables 4, 3e). Lauric acid (C12:0) exhibited a signifi-
cant decrease in concentration from day 15 to day 180
(Tables 4, 3d). Caprylic acid (C8:0) showed a slight in-
crease in concentration at day 30, followed by a signifi-
cant decrease until reaching 3.79% at day 180 (Tables 4,
3b). Capric acid (C10:0), after a slight increase between
15 and 30 days, declined in concentration significantly
to 5.86% at day 180 (Tables 4, 3c). The stearic acid con-
centration did not vary significantly over time (Table 4).
Unsaturated fatty acid
The overall unsaturated fatty acid (UFA) content of the
milk was 48.02 ± 2.97% (Table 2) and increased during
the lactation period (Figure 1A). The mean UFA/SFA
ratio was 0.92, which underwent a significant increase
over time, reaching a value greater than 1% at day 120
and a peak of 1.50% at day 180 (Figure 1B, Table 3 g).
The overall MUFA content was 28.00 ± 3.91% (Table 2).
The stage of lactation affected (0.05 > P < 0.01) the MUFA
content. The total MUFA increased (P<0.01) during lac-
tation from 23.58% at day 15 to 34.40% at day 180 and
then decreased slightly at day 210 (Figure 1A, Table 5a).
The individual MUFA profiles are reported in Table 4.
Oleic acid (C18:1 n-9) was the most representative of
MUFA (21.50%, average), with a significant (Table 5 g)Monounsaturated (MUFA, %) 28.00 ± 3.91
Polyunsaturated (PUFA, %) 20.02 ± 2.04
of which
PUFA n-3 (%) 7.12 ± 1.96
PUFA n-6 (%) 12.90 ± 2.13
PUFA n-3/n-6 ratio 0.59 ± 0.08
UFA/SFA ratio 0.92 ± 0.07
Desaturase index1
cis-9 14:1 0.04 ± 0.01
cis-9 16:1 0.14 ± 0.03
cis-9 18:1 0.93 ± 0.01
Atherogenic index (AI)2 1.16 ± 0.28
Thrombogenic index (TI)3 0.70 ± 0.14
1Ratio of Δ9-desaturase product divided by the sum of the Δ9-desaturase
product and product.
2, 3Calculated using the equation described by Ulbricht and Southgate (1991).
Figure 1 Variations of fatty acid composition and indices for human health of milk during the lactation period: (A) saturated (SFA),
unsaturated (UFA), monounsaturated (MUFA) and polyunsaturated fatty acids (PUFA); (B) UFA/SFA and PUFA n-3/n-6 fatty acids ratios;
(C) atherogenic (AI) and thrombogenic (TI) indices (mean ± SD).
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(27.57%). The average palmitoleic acid (C16:1) content
was 3.45%. It decreased from early lactation to day 90,
then increased significantly (Table 5e), reaching its max-
imum level at day 210.
Among the MUFAs found at a concentration greater
than 1%, the content of decenoic acid (C10:1=1.16%, aver-
age) decreased significantly during lactation (Tables 4, 5b).
The miristoleic acid (C14:1) content exhibited a decreasingtrend, from day 15 to day 180, and then increased at day
210 (Tables 4, 5c).
With respect to milk fatty acid pairs representing
product/substrate ratios and related to the Δ9-desaturase
system (Table 2), a higher desaturase index was observed
(P < 0.01) for cis-9 18:1 (0.93, average) than for cis-9
16:1 (0.14, average) and cis-9 14:1 (0.04, average). The
stage of lactation affected (P < 0.01) the Δ9-desaturase
ratios (Table 4), with a significant increase mainly in cis-
Table 3 Statistical differences in (a) SFA (saturated fatty acids), (b) C8:0, (c) C10:0, (d) C12:0, (e) C14:0, (f) C16:0 and (g) UFA (unsaturated fatty acids)/SFA ratio
of milk in relation to the lactation stage of jennies (*: P < 0.05; **: P < 0.01; ns: not significant)
(a) SFA (c) C10:0
(b) C8:0 15d 30d 45d 60d 90d 120d 150d 180d 210d (d) C12:0 15d 30d 45d 60d 90d 120d 150d 180d 210d
15d ns ns ns ** ** ** ** ** 15d ns ns ns ns ** ** ** **
30d ns ns ns ** ** ** ** ** 30d ns ns ns ns ** ** ** **
45d ns ns ns ns ** ** ** ** 45d ns ns ns ns ** ** ** **
60d * ns ns ns ** ** ** ** 60d ns ns ns ** ** ** **
90d ns ns ns ns ns ns ** * 90d * ns ns ns ** * ** *
120d ns ns ns ** ** ns * ns 120d ** ns * ns ns ns ns ns
150d ns ** ** ** * ns ns ns 150d ** * ** * ns ns ns ns
180d ns ** ** ** ** ns ns ns 180d ** ** ** ** * ns ns ns
210d ns ** * ** * ns ns ns 210d ** * ** ** ns ns ns ns
(e) C14:0 (g) UFA/SFA
15d 30d 45d 60d 90d 120d 150d 180d 210d 15d 30d 45d 60d 90d 120d 150d 180d 210d
(f) C16:0 15d ns ns * ** ** ** ** ** 15d ns ns ns * ** ** ** **
30d ** ns ns * * ** ** ** 30d ns ns ns ** ** ** **
45d ns ns ns ns ns ** ** ** 45d ns ns ** ** ** **
60d ** ns ns ns ns * ** * 60d ns ** ** ** **
90d ** ns ns ns ns ns * ns 90d ns ns ** ns
120d ** ns ns ns ns ns ns ns 120d ns * ns
150d ns ** ns ns ** ns ns ns 150d ns ns
180d * ns ns ns ns ns ns ns 180d ns

























Table 4 Saturated, monounsaturated, polyunsaturated fatty acid profile (% of fatty acids) and desaturase index durin the lactation period (210days)
LACTATION STAGE Effect of
Lactation stage115 d 30 d 45 d 60 d 90 d 120 d 150 d 180 d 210 d
Saturated Fatty Acids (SFA)
Butyric Acid C4:0 0.51 0.61 0.28 0.51 0.4 0.57 0.59 0.15 0.23 *
Caproic Acid C6:0 0.52 0.72 0.58 0.72 0.71 0.64 0.61 0.37 0.59 *
Heptanoic Acid C7:0 0.02 0.01 0.02 0.01 0.01 0.03 0.02 0.01 0.03 ns
Caprylic Acid C8:0 5.30 6.76 6.13 6.87 6.07 4.57 4.39 3.79 4.73 *
Nonanoic Acid C9:0 0.04 0.03 0.03 0.03 0.03 0.03 0.03 0.04 0.03 ns
Capric acid C10:0 12.01 13.46 11.75 11.93 9.82 7.62 7.19 5.82 6.66 **
Undecanoic acid C11:0 0.03 0.03 0.02 0.02 0.02 0.02 0.02 0.02 0.01 ns
Lauric acid C12:0 10.82 10.87 9.47 9.27 7.55 6.42 5.84 4.44 5.32 **
Tridecanoic acid C13:0 0.04 0.05 0.06 0.06 0.05 0.04 0.03 0.03 0.04 ns
Myristic Acid C14:0 8.66 7.80 7.20 6.82 5.79 5.60 5.08 3.91 4.95 **
Pentadecanoic Acid C15:0 0.22 0.23 0.23 0.23 0.24 0.23 0.23 0.20 0.22 ns
Palmitic Acid C16:0 22.37 18.33 19.56 19.06 18.53 19.61 20.83 19.82 19.47 *
Margaric acid C17:0 0.22 0.22 0.24 0.24 0.26 0.26 0.24 0.22 0.22 ns
Stearic Acid C18:0 1.88 1.48 1.64 1.99 1.68 1.75 1.52 1.49 1.44 ns
Arachidic Acid C20:0 0.10 0.09 0.08 0.09 0.09 0.10 0.08 0.09 0.07 ns
Heneicosanoic Acid C21:0 0.03 0.04 0.02 0.04 0.03 0.02 0.02 0.03 0.02 ns
Behenic Acid C22:0 0.04 0.10 0.15 0.06 0.07 0.19 0.15 0.05 0.04 ns
Lignoceric Acid C24:0 0.06 0.11 0.07 0.08 0.09 0.09 0.06 0.08 0.06 ns
Monounsaturated Fatty Acids (MUFA)
Decenoic Acid C10:1 1.38 1.64 1.25 1.36 1.08 0.91 0.84 0.76 1.20 *
Dodecenoic Acid C12:1 0.17 0.18 0.14 0.15 0.11 0.11 0.10 0.08 0.13 ns
Tridecenoic acid C13:1 0.04 0.04 0.04 0.04 0.04 0.04 0.03 0.09 0.05 ns
Myristoleic Acid C14:1 0.38 0.34 0.29 0.26 0.21 0.26 0.25 0.21 0.32 *
Pentadecenoic acid C15:1 0.07 0.08 0.08 0.06 0.07 0.07 0.06 0.06 0.08 ns
Palmitoleic Acid C16:1 3.02 2.79 2.98 2.36 2.28 3.22 4.23 4.48 5.67 *
Heptadecenoic Acid C17:1 0.30 0.29 0.33 0.33 0.31 0.34 0.38 0.31 0.40 ns
Oleic Acid C18:1 n-9 17.55 16.65 18.62 19.36 21.29 23.74 25.05 27.57 23.73 **
Gadoleic Acid C20:1 n-9 0.25 0.31 0.37 0.42 0.45 0.49 0.38 0.39 0.34 ns
Erucic Acid C22:1 n-9 0.40 0.31 0.64 0.44 0.75 0.81 0.59 0.46 0.37 ns
Nervonic Acid C24:1 0.01 0.02 0.03 0.01 0.02 0.01 0.01 0.05 0.02 ns
Polyunsaturated Fatty Acids (PUFA)
Linoleic Acid C18:2 n-6 8.83 9.76 10.76 11.20 15.15 14.64 12.93 17.20 11.03 **

























Table 4 Saturated, monounsaturated, polyunsaturated fatty acid profile (% of fatty acids) and desaturase index during the lactation period (210days)
(Continued)
Stearidonic Acid C18:4 n-3 0.01 0.02 0.02 0.02 0.02 0.03 0.03 0.03 0.03 ns
Eicosadienoic Acid C20:2 n-6 0.22 0.20 0.30 0.29 0.36 0.34 0.23 0.24 0.19 ns
Eicosatrienoic Acid C20:3 n-3 0.03 0.03 0.03 0.03 0.04 0.03 0.03 0.04 0.03 ns
Arachidonic Acid C20:4 n-6 0.08 0.13 0.08 0.08 0.08 0.08 0.09 0.10 0.11 ns
Eicosatetraenoic Acid C20:4 n-3 0.10 0.10 0.14 0.14 0.13 0.13 0.16 0.14 0.24 ns
Eicosapentaenoic Acid C20:5 n-3 0.23 0.30 0.56 0.48 0.65 0.71 0.49 0.55 0.51 ns
Docosadienoic Acid C22:2 n-6 0.05 0.06 0.08 0.06 0.10 0.11 0.12 0.10 0.09 ns
Docosatrienoic Acid C22:3 n-3 0.00 0.01 0.00 0.02 0.01 0.01 0.01 0.01 0.01 ns
Docosatetraenoic Acid C22:4 n-6 0.05 0.05 0.05 0.04 0.07 0.09 0.03 0.05 0.03 ns
Docosapentaenoic Acid C22:5 n-3 0.04 0.03 0.07 0.03 0.03 0.04 0.04 0.13 0.05 ns
Docosahesaenoic Acid C22:6 n-3 0.04 0.01 0.03 0.02 0.02 0.02 0.02 0.03 0.02 ns
Δ9-desaturase ratiosa
cis-9 14:1 0.04 0.04 0.04 0.04 0.03 0.04 0.05 0.06 0.06 *
cis-9 16:1 0.12 0.13 0.13 0.11 0.11 0.14 0.16 0.17 0.22 **
cis-9 18:1 0.90 0.92 0.92 0.91 0.93 0.93 0.94 0.95 0.94 **
a Ratio of the Δ9-desaturase product divided by the sum of Δ9-desaturase product and product as described in Materials and Methods.

























Table 5 Statistical differences in (a) MUFA (monounsaturated fatty acids), (b) C10:1, (c) C14:1, (d) C14:1/C14:0, (e) C16:1, (f) C16:1/C16:0, (g) C18:1 and (h)
C18:1/C18:0 of milk in relation to the lactation stage of jennies (*: P < 0.05; **: P < 0.01; ns: not significant)
(a) MUFA (c) C14:1
(b) C10:1 15d 30d 45d 60d 90d 120d 150d 180d 210d (d) C14:1/ C14:0 15d 30d 45d 60d 90d 120d 150d 180d 210d
15d ns ns ns ns * ** ** ** 15d ns ns * ** * * ** ns
30d ns ns ns ns ** ** ** ** 30d ns ns ns ** ns ns * ns
45d ns ns ns ns ns ** ** ** 45d ns ns ns ns ns ns ns ns
60d ns ns ns ns ns ** ** ** 60d ns ns ns ns ns ns ns ns
90d ns ** ns ns ns * ** * 90d ns ns ns ns ns ns ns *
120d ** ** ** ** ** ns ns ns 120d ns ns ns ns ns ns ns ns
150d ** ** ** ** * ns ns ns 150d ns ns ns * * ns ns ns
180d ** ** ** ** ** ns ns ns 180d ns ns ns * * ns ns *
210d ** ** ** ** * ns ns ns 210d ** ** ** ** ** ** ** *
(e) C16:1 (g) C18:1
15d 30d 45d 60d 90d 120d 150d 180d 210d (h) C18:1/ C18:0 15d 30d 45d 60d 90d 120d 150d 180d 210d
(f) C16:1/ C16:0 15d ns ns ns ns ns ns ns ** 15d ns ns ns ns ** ** ** **
30d ns ns ns ns ns ns ns ** 30d ns ns ns * ** ** ** **
45d ns ns ns ns ns ns ns ** 45d ns ns ns ns * ** ** **
60d ns ns ns ns ns ns * ** 60d * ns ns ns * ** ** *
90d ns ns ns ns ns * * ** 90d ns ns ns ns ns ns ** ns
120d ns ns ns ns ns ns ns ** 120d * ns ns ns ns ns ns ns
150d ns ns ns * * ns ns ns 150d ** * * ** ns ns ns ns
180d ns ns ns * * ns ns ns 180d ** ** * ** ns ns ns ns

























Table 6 Statistical differences in (a) PUFA (polyunsaturated fatty acids), (b) PUFA n3/n6 ratio, (c) C18:2, (d) C18:3, (e) AI
(atherogenic index) and (f) TI (thrombogenic index) of milk in relation to the lactation stage of jennies (*: P < 0.05; **:
P < 0.01; ns: not significant)
(a) PUFA (c) C18:2
15d 30d 45d 60d 90d 120d 150d 180d 210d (d) C18:3 15d 30d 45d 60d 90d 120d 150d 180d 210d
(b) n3/
n6
15d ns ** * ** ** ** ** ** 15d ns ns ns ** ** ** ** **
30d ns ns ns ** ** ** ** ** 30d ns ns ns ** ** * ** ns
45d ns ns ns ** ** * ** ** 45d ns ns ns ** ** ns ** ns
60d ns ns ns ** ** ** ** ** 60d ns ns ns ** * ns ** ns
90d ns ns ns ns ns ns * ns 90d ns ns ns ns ns ns ns **
120d ns ns ns ns ns ns ns ns 120d ns ns ns ns ns ns ns ns
150d ns ns ns ns ns ns ** ns 150d * ns ns ns ns ns ns ns
180d ns ns ns ns ns ns ns ns 180d ns ns ns ns ns ns ns **
210d ** ** ns ns ns ns ** ** 210d ** ** ** ** ** ** ** **
(e) AI
15d 30d 45d 60d 90d 120d 150d 180d 210d
(f) TI 15d ns * ** ** ** ** ** **
30d ** ns ns ** ** ** ** **
45d ** ns ns ** ** ** ** **
60d ** ns ns ns * * ** **
90d ** ns ns ns ns ns ns ns
120d ** ns ns ns ns ns ns ns
150d ** ns ns ns ns ns ns ns
180d ** ** ** ** ns ns ns ns
210d ** ** ** ** ** ns ** ns
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lactation progressed.
Among the observed UFAs, the contents of PUFAs
were lower (P < 0.05) than those of MUFAs (Table 2).
The total PUFA contents were affected by the stage of
lactation (P < 0.01), increasing (P < 0.01) from day 15 to
day 45 and then until day 180 (Figure 1A, Table 6a).
The PUFA n-6 content of milk fat was higher than
that of the PUFA n-3 series (Table 2); both increased
during lactation. The PUFA n-6 content underwent a
significant increase from day 15 (9.19%) to day 90
(15.70%; P < 0.01), reached a maximum value at day 180
(17.65%; P < 0.01) and then decreased at day 210
(11.44%) (data not provided). The PUFA n-3 content
increased during the lactation period, reaching a peak at
day 210 (12.08%; P < 0.01).
Among the PUFA of the n-6 series, the most abundant
acid was linoleic acid (C18:2 n-6, LA=18.38%, average).
The LA content was 8.83% at day 15, with a significant
increase at day 90 and the highest level at day 180
(17.20%), which was followed by a marked decrease at
day 210 (Tables 4, 6c).
Among the PUFAs of the n-3 series, alpha-linolenic
acid (ALA, C18:3 n-3) was the most represented (6.19%,
average). The ALA content underwent a significant in-
crease from 3.85% at day 15 to 6.36% at day 150 andreached a maximum level at day 210 (11.17%) (Tables 4,
6d).
Among the minor PUFAs, eicosadienoic (C20:2 n-6),
arachidonic (AA, C20:4 n-6), eicosapentanoic (EPA,
C20:5 n-3), eicosatetranoic (ETA, C20:4 n-3) and doco-
sahesaenoic (DHA, C22:6 n-3) acid were present at
mean concentrations of 0.26%, 0.09%, 0.50%, 0.14% and
0.02%, respectively (data not presented); no significant
variations were observed during the lactation period
(Table 4).
The overall PUFA n-3/n-6 ratio was 0.59 (Table 2),
with a significant increase from early lactation to a max-
imum value at day 210 (Figure 1B, Table 6b).
The means of the AI and TI were 1.16 and 0.70,
respectively (data not presented) and were significantly
(P < 0.01) affected by the lactation stage. The AI
decreased markedly from day 15 to day 45, reaching
values less than 1 at day 120 and a minimum at day 180
(0.68) (Figure 1c, Table 6e). The TI decreased over time
showing a significant drop at day 30 until reaching the
lowest value of 0.44 at day 210 of lactation (Figure 1C,
Table 6f ).
Discussion
The observed low average milk fat content is consistent
with that reported in the literature for donkey’s milk
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cows and humans [27].
The fat content was affected by the stage of lacta-
tion, showing a decreasing trend, which is in agree-
ment with the results observed for the Ragusana breed
[10,28], Litoral-Dinaric donkeys [25], mares [9,29,30]
and cows [31].
The low fat content of milk and its variations during
the lactation period corresponded to a low energetic
value with the same trend during lactation. The gross
energy content of the milk was similar to that recorded
by Salimei et al. [11]. Compared with the energetic value
of milk from different species, that of donkey milk is
slightly lower than that of mare milk [29,32] and lower
than that of cow and human milk [27]. This finding
could be a limiting factor in its use in infant nutrition
within a diet exclusively based on milk. Thus, it has been
suggested that an appropriate modification in the com-
position of donkey’s milk be made for infant feeding [33]
by adding medium-chain triglycerides or sunflower oil
[34,35]. However, the low fat content and energetic value
of this milk suggests its potential use in hypocaloric
human diets.
The decreasing energy content of donkey’s milk during
lactation agrees with the trend observed in mares
[29,32], although Salimei et al. [11] did not observe any
considerable variation in fat content or energy value dur-
ing lactation, which is likely due to different experimen-
tal conditions.
The SFAs were the most representative fatty acids, in
agreement with the results of other studies [36,37] and
comparable to the composition of mare [38] and human
milk [27]; however, its content were observed to be
lower than those observed in ruminant milk [5]. The
short-chain fatty acids and medium-chain fatty acids
contents as in mares, were observed to be lower than
those observed in cow’s milk and higher than those
observed in human milk [26,39]. The high fatty acid
content < C16 content observed in this study, with re-
spect to other monogastric species [9], agrees with the
results from equine studies and could be attributed to
their synthesis from acetate and 3-hydroxybutyrate, as
observed in ruminants, and not from glucose as occurs
in monogastrics [9,40]. Furthermore, instead of rumi-
nants, fatty acid de novo synthesis in equines includes
parts of C18 next to C4 and C14 and parts of C16 fatty
acids [40].
Among the observed SFA, butyric (C4:0) and caproic
(C6:0) acids were observed in concentrations less than
1%, as has been observed in mares [26]. The average
amounts of caprylic (C8:0), capric (C10:0) and lauric
(C12:0) acids were lower than those reported for Ragu-
sana jennies (12.80%, 18.65%, and 10.67%, respectively;
[41]); this finding is likely related to differences in breedand/or body conditions. The caprylic (C8:0) acid content
was higher compared with that reported for mares
(3.1%), cows (1.3%) and human milk (traces) [40].
Among the observed SFAs, palmitic acid (C16:0) was
observed at the highest concentration, in agreement with
the results reported in other related studies [28,37] and
in studies on mares [26]; however, the content was less
than that of cow and human milk [26,39].
During the early lactation period (15–30days), the milk
was observed to contain more C4:0 to C14:0 than during
the middle (day 120) and late (day 210) lactation periods,
most likely due to an increased synthesis of C4 to C14
fatty acids in the mammary gland during the early lacta-
tion period, as has been observed in cows [42].
Long-chain fatty acids such as stearic acid (C18:0)
were observed in modest amounts, consistent with the
results reported for other breeds [37,41] as well as for
mares (1.55%) [9,43], while it has been recorded at
higher levels in cow and human milk (7-13%) [26,27,37].
As in equines, the low stearic acid content could be
attributed to a low stearic acid content in the animals’
diets and to a high activity of Δ9-desaturase on the con-
version of stearic acid (C18:0) into oleic acid (C18:1),
which is further enhanced by a high palmitoleic acid
(C16:1) content [26], as was observed in this study.
The SFA content decreased during lactation. A higher
decrease was observed for lauric (C12:0, -59%) and myr-
istic (C14:0, -54.5%) acids and a lower decrease for pal-
mitic acid (C16:0, -17%), likely due to a decrease in the
concentration of the precursors of de novo synthesis. A
decrease in the short- and medium-chain fatty acid con-
tents during lactation has also been reported in mares
[9,44], while small changes in the SFA content have been
observed in human milk [45]; additionally, increases in
these fatty acid contents have been observed in cow’s
milk [46].
From a nutritional standpoint, it has been reported that
C18 SFA has a neutral health effect, while C4 to C10 SFAs
have positive effects and C12 to C16 SFAs have negative
health effects [47]. In particular, SFAs C14 - C16 are con-
sidered dangerous because they are associated with high
serum LDL-cholesterol concentrations in human subjects
[48]. Medium-chain fatty acids are characterised by better
absorption than long-chain fatty acids [49]. Furthermore, it
has been suggested that equids’ milk is more digestible than
cow’s milk, according to experiments performed on rats,
and allows for faster evacuation of the stomach [26].
The UFA content, in agreement with other studies
(50.69%) [13], was similar to that of mare’s and human
milk but higher than that reported for ruminant’s milk
(23-32%) [27,41].
The UFA/SFA ratio is comparable to mare’s milk [27] and
higher than that recorded in the Ragusana donkey (0.48) and
that reported for ruminant’s milk (0.26-0.41) [41,47].
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leic (C16:1 n-7) acid contents were higher than those
observed in donkey’s milk by other researchers [11,41],
likely due to different experimental conditions; these con-
tents were observed to be similar to those reported for
mares but lower than those in human milk (C18:1, 46%)
[30].
The MUFA content increased during the lactation
period, whereas Chiofalo et al. [28] did not find significant
variability throughout lactation in the Ragusana breed,
most likely due to different experimental conditions.
In this study, the amount of desaturation, calculated
from the ratio of Δ9-desaturase product/sum of Δ9-desa-
turase product and substrate, was relatively high for
C18:1 and C16:1 and increased as lactation progressed,
reaching higher values at 150 to 210 days of lactation.
This result may explain the observed high value of these
MUFAs in milk and their increased trend during lacta-
tion. Moreover, it has been reported that preformed fatty
acids, such as oleic acid, could be derived from mobilisa-
tion from adipose tissue or from absorption from the di-
gestive tract, with an increase being observed for a
forage diet [26,44], which likely occurred in this study
for the asses fed on pasture.
It has been reported that in the human diet the high
relative percentage of MUFA has beneficial effects with
respect to arterial disease, i.e., it lowers plasma LDL
cholesterol and total cholesterol as well as the fibrino-
lytic activity of circulating plasma by modifying vascular
endothelial physiology [50], while the intake of SFA is a
risk factor in contracting coronary heart disease [51].
Among PUFAs and EFAs, LA (C18:2 n-6) and ALA
(C18:3 n-3) acid were the most representative of PUFA
n-6 and PUFA n-3, respectively, exhibiting higher values
than those of the Ragusana breed [41] and comparable
to the range recorded in mares [30] but higher than that
reported in ruminant’s milk [47]. Furthermore, the n-3/
n-6 fatty acid ratio was higher than that recorded in
Ragusana asses (0.19) [52] and higher than that reported
in humans (0.012) or in cows (0.28) [37]. As in equines,
according to other researchers [19,30], the reasons for
this difference could be related to the amounts of these
acids in the animals’ diets and the absence of biohydro-
genation of fatty acids in the digestive tract before ab-
sorption, unlike what occurs in ruminants [53].
In humans, LA has been reported to play a role in the
prevention of gastric ulcers. It is a precursor of prosta-
glandin E that increases with stimulation by linoleic acid
[54]. Prostaglandins are involved in the prevention of
gastric ulcers through a rise in mucosal protective fac-
tors; this prevention is important in foals, which have a
certain incidence of gastric ulcers [55].
In agreement with the results of Gastaldi et al. [37],
the percentage of ALA was higher compared with thatof human’s (1.14%) and cow’s milk (0.48%) whereas the
LA content was similar to that reported for human milk.
The ALA content increased during the lactation period,
consistent with the results observed for mares [56], and
the maximum level was achieved late in the lactation
period. This result reflects the higher PUFA n-3/n-6 ratio
at the 7th month of lactation (day 210). This higher ratio
may be explained by the increase in pasture feeding by
jennies on richer grass during the late lactation period.
Grass is rich in ALA content, and no biohydrogenation
occurs before absorption [30]. Furthermore, higher ALA
contents have been reported in milk from asses [57] and
mares [26] fed on herbage rather than hay.
AI and TI, which indicate the healthfulness of milk
with respect to fatty acid content and their potential to
prevent or cause atherosclerosis and thrombosis, were
observed to be present in lower quantities than in cow’s
milk (2.51 and 1.86, respectively) [58].
It should be noted that LA is the precursor of PUFA
n-6, and AA (C20:4 n-6) and ALA are the precursors of
PUFA n-3, EPA (C20:5 n-3) and DHA (C22:6 n-3) acids.
AA and EPA/DHA are substrates for the formation of
eicosanoids [59]. Prostaglandins and leukotrienes are im-
portant in controlling several cell activities [60], and
DHA is important in the development of the central
nervous system [61]. The role of PUFA is important in
the development of the neonatal brain as well as in the
development of the retina and cognitive functions
[62-64]. The high content of n-3 fatty acids in donkey
milk could have a significant effect on the development
of the neural system, vision and infant growth.
Among the minor PUFA observed in this study, small
amounts of EPA, DHA and AA were observed, consistent
with other studies on donkey’s milk [11,37,41] and mare’s
milk [26]. The percentage of EPA was higher compared
with human milk (0.27%); in contrast, the DHA and AA
contents were lower (0.40 and 0.59%) [37]. The reasons
for this result are likely due to the different elongation and
desaturation processes in mammary glands. A higher AA/
EPA ratio in breast milk from the mothers of atopic
infants compared with non-atopic infants [65] and the re-
lationship between lower levels of EPA and the early de-
velopment of atopic disease have been reported. The low
AA/EPA ratio observed in this study (0.18), with respect
to those reported for human’s and cow’s milk (29.5 and
3.67) [37], suggests that donkey milk could be used in
childhood nutrition to prevent the risk of developing ato-
pical diseases. Moreover, donkey’s milk could be useful in
pre-term infants’ diets because premature infants seem
able to form AA from linoleic acid and EPA and DHA
from α-linolenic acid [66,67]. The positive effects of don-
key’s milk in infant nutrition has been demonstrated in
the treatment of multiple food intolerances [34,68,69] and
in selected cases of cow’s milk allergies [7,70].
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suggest that this milk may also be used adult human
diets. From a nutritional point of view, it has been
reported that the rapid changes in the diet of the
Western industrialised society, mainly over the last 150
years with respect to the ancestor-constituted genetic
profile, involve a particular increase in saturated fats and
n-6 fatty acids and a decrease in n-3 fatty acids [71-74].
The levels of long-chain n-6 to n-3 (mainly LA com-
pared with ALA) fatty acids are important, particularly
n-3 fatty acids [75], in maintaining cardiovascular health
[76,77] and they influence the ratios of ensuing eicosa-
noids and metabolic functions [59]. The dietary balance
of the ratios of n-6 to n-3 PUFA affects the regulation of
metabolic functions [78] and the development of meta-
bolic syndrome, including lipid profile and adiposity, in-
sulin sensitivity and inflammation [79,80]. It has been
estimated that the ratio of n-6 to n-3 fatty acids in the
Western diet is 15-20/1, and more n-3 than n-6 fatty
acids have been suggested, with a ratio that tends to-
wards 1:1 [81].
In this study, the PUFA n-6 to n-3 ratio and the LA/
ALA ratio, in particular, were approximately 2:1, with a
lower value (< 1) during the 7th month of lactation due
to a high increase in the ALA content, potentially sug-
gesting the more optimal use of milk collected during
this period.
In addition to the benefits related to coronary health
disease, the beneficial health effects of n-3 fatty acids in-
clude those related to inflammatory disease, such as
rheumatoid arthritis [82], dermatitis [83,84], cancer [85],
depression and dementia, and may be potentially used to
treat late-onset Alzheimer’s disease [86,87].
Long-chain PUFA n-3 has been shown to induce immu-
nomodulatory activity on natural and acquired immunity
[88,89] through the synthesis of lipid mediators (pros-
taglandins, leukotrienes), peptide mediators (cytokines),
reactive oxygen species (superoxide), and enzymes. The
metabolites of n-3 fatty acids are less inflammatory than
those of n-6 (in particular, AA). The eicosanoid derived
from AA, i.e, prostaglandin E2 and leukotriene B4, pro-
mote atopic inflammation; in contrast, PUFA n-3 and
their derived eicosanoid influence AA metabolism, pro-
moting anti-inflammatory properties [90,91]. The high
PUFA n-3 content in donkey’s milk could have a func-
tional effect on the immunological system. In our study
on an in vitro model of human peripheral blood mono-
nuclear cells [6,92], donkey milk exhibited the ability to
induce IgG secretion and the release of interleukins
(IL-12, IL-1β, IL-10) and TNF-α - important to the immu-
notreatment of immune-related disease - and a high re-
lease of nitric oxide (NO), a potent promoter in the
prevention of atherosclerosis. Indeed, NO is a strong vaso-
dilator of terminal vessels, improves blood flow, and is aneffective antimicrobial agent in the development of ath-
erosclerosis [93]. In combination, these results support
the concept that donkey’s milk, likely due to its high
PUFA n-3 content, can prevent atherosclerosis via the
production of NO and, at moderate intake level (200 mL/
d; [94]), can up-regulate the immune response in elderly
hosts.
Conclusions
Donkey milk is characterised by low fat and energetic
values, a high PUFA content composed mainly of ALA
(18:3 n-3) and LA (18:2 n-6), a low ratio of n-6 to n-3
fatty acids or LA/ALA ratio and advantageous values of
AI and TI. Among minor PUFA, DHA, EPA, and AA
were present in minute amounts.
The fat and energetic values decreased during lacta-
tion. The fatty acids patterns were influenced by the lac-
tation stage, showing a decrease in SFA content and an
increase in UFA content, with higher values being
recorded during the late lactation period. During this
period, lower values of the n-6/n-3 ratio (<1) were also
observed. The higher PUFA n-3 content and lower
PUFA n-6/n-3 and AA/EPA ratios of donkey’s milk with
respect to cow’s milk may be of particular interest in
adopting donkey’s milk for infant nutrition. Considering
the low lipid and energetic value content, donkey’s milk
could be used within well-balanced and integrated hypo-
caloric diets. The recorded high PUFA content and low
n-6/n-3 or LA/ALA ratios in donkey milk could make it
interesting for adult human nutrition.
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